Anti-Human CCR8 Monoclonal Antibody, clone: lanerkitug, Ships in 3-5 Weeks

Anti-Human CCR8 Monoclonal Antibody, clone: lanerkitug Clone: lanerkitug                      Catalog#: N24024 Description:   Lanerkitug is an immunoglobulin G1-lambda2 monoclonal antibody that targets CCR8. CCR8 is mainly highly expressed on regulatory T cells (Tregs) in the tumor microenvironment, while it is lowly expressed in surrounding normal tissues and peripheral blood. Therefore, CCR8 can serve as a specific biomarker for Treg cells and is a potential therapeutic target and biomarker. The high expression of CCR8 is associated with a variety of cancers, including colorectal cancer, breast cancer, and gastric cancer. It is considered to be a potential specific marker of Treg at the tumor site and a potential tumor immune target. Reactivities: Human Target: CCR8 Clone: lanerkitug Isotype: immunoglobulin G1-lambda2 Alternative Name: C-C motif chemokine receptor 8, CKR-L1, CDw198 Recommended Dilution Buffer: PBS, pH 7.4,Contains no